Title: Developmental programming: Prenatal testosterone excess disrupts pancreatic islet developmental trajectory in female sheep.
Authors: Jackson, Ian J; Puttabyatappa, Muraly; Anderson, Miranda; Muralidharan, Meha; Veiga-Lopez, Almudena; Gregg, Brigid; Limesand, Sean; Padmanabhan, Vasantha
Published In Mol Cell Endocrinol, (2020 12 01)
Abstract: Prenatal testosterone (T)- treated female sheep manifest juvenile insulin resistance, post-pubertal increase in insulin sensitivity and return to insulin resistance during adulthood. Since compensatory hyperinsulinemia is associated with insulin resistance, altered pancreatic islet ontogeny may contribute towards metabolic defects. To test this, pregnant sheep were treated with or without T propionate from days 30-90 of gestation and pancreas collected from female fetuses at gestational day 90 and female offspring at 21 months-of-age. Uterine (maternal) and umbilical (fetal) arterial blood insulin/glucose ratios were determined at gestational day 90. The morphological and functional changes in pancreatic islet were assessed through detection of 1) islet hormones (insulin, glucagon) and apoptotic beta cells at fetal day 90 and 2) islet hormones (insulin, glucagon and somatostatin), and pancreatic lipid and collagen accumulation in adults. At gestational day 90, T-treatment led to maternal but not fetal hyperinsulinemia, decrease in pancreatic/fetal weight ratio and alpha cells, and a trend for increase in beta cell apoptosis in fetal pancreas. Adult prenatal T-treated female sheep manifested 1) significant increase in beta cell size and a tendency for increase in insulin and somatostatin stained area and proportion of beta cells in the islet; and 2) significant increase in pancreatic islet collagen and a tendency towards increased lipid accumulation. Gestational T-treatment induced changes in pancreatic islet endocrine cells during both fetal and adult ages track the trajectory of hyperinsulinemic status with the increase in adult pancreatic collagen accumulation indicative of impending beta cell failure with chronic insulin resistance.
PubMed ID: 32726642
MeSH Terms: Animals; Animals, Newborn; Apoptosis/drug effects; Embryonic Development/drug effects*; Embryonic Development/physiology; Female; Fetus/drug effects; Fetus/metabolism; Hyperandrogenism/embryology; Hyperandrogenism/metabolism; Hyperandrogenism/pathology; Hyperinsulinism/chemically induced; Hyperinsulinism/embryology; Hyperinsulinism/metabolism; Hyperinsulinism/pathology; Insulin-Secreting Cells/drug effects; Insulin-Secreting Cells/physiology; Insulin/metabolism; Islets of Langerhans/drug effects*; Islets of Langerhans/embryology*; Islets of Langerhans/metabolism; Pancreas/drug effects; Pancreas/embryology; Pancreas/metabolism; Pregnancy; Prenatal Exposure Delayed Effects*/chemically induced; Prenatal Exposure Delayed Effects*/metabolism; Prenatal Exposure Delayed Effects*/physiopathology; Sheep; Testosterone/pharmacology*